Context Therapeutics Stock Forecast

CNTX's stock price has decreased by -71.65% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 4 analysts that cover Context Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $6, which forecasts a 947.85% increase in the stock price over the next year. The lowest target is $4 and the highest is $9.

Price Target: $6 (+947.85%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$6.00	$5.00	$9.00
Change	+598.57%	+947.85%	+773.21%	+1471.8%

* Price targets were last updated on May 8, 2025.

Analyst Ratings

The average analyst rating for Context Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	3	3	3	3	3	2
Buy	2	2	2	3	3	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	6	6	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $9	Strong Buy	Maintains	$9	+1,471.78%	May 8, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $9	Strong Buy	Maintains	$9	+1,471.78%	Apr 29, 2025
Matt Phipps William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Apr 21, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $9	Strong Buy	Maintains	$9	+1,471.78%	Apr 9, 2025
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+773.21%	Mar 21, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 56.70M

Revenue Next Year

n/a

EPS This Year

-0.25

from -0.46

EPS Next Year

-0.32

from -0.25

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	-	9.25M	56.70M
Revenue Growth	-	-	-	-	513.33%	-	-	-
EPS	-3.96	-3.69	-0.93	-1.50	-0.46	-0.25	-0.32	-0.37
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-0.23	-0.27	-0.29
Avg	-0.25	-0.32	-0.37
Low	-0.27	-0.37	-0.43

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.